Kezar Life Sciences, Inc. (KZR) Misses Q4 EPS by 6c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q4 EPS of ($0.44), $0.06 worse than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Elevance (ELV) PT Raised to $482 at Bernstein SocGen
• SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg